Daiichi Sankyo is no longer best understood as a successful Japanese pharma company with a strong […]
Stylized wide illustration of Japan as a connected bioeconomy ecosystem, with biopharma, diagnostics, data, biomanufacturing, and global collaboration hubs linked through clean pathways around a central innovation hub.
Japan wants biotechnology to become a larger part of its economy by 2030. That is the […]
Editorial illustration showing complex healthcare data, regulatory, and localization inputs being streamlined through a Japan-themed gateway into clear eCOA/ePRO digital tools used by a doctor and patient.
Japan is one of the world’s most demanding healthcare markets. It is also one of the […]